Using chlorhexidine dressings to prevent infections in pediatric cancer patients with catheters
Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheter-Related Bloodstream Infections in Pediatric Cancer Patients
This study is testing if using special dressings with chlorhexidine can help prevent infections in young cancer patients who have catheters.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 1 Year to 17 Years |
| Sex | All |
| Sponsor | Dokuz Eylul University Academic / other |
| Locations | 1 site (Izmir) |
| Trial ID | NCT06720064 on ClinicalTrials.gov |
What this trial studies
This study examines the effectiveness of a care bundle that includes chlorhexidine dressings in reducing catheter-related bloodstream infections in pediatric patients with cancer. It is a prospective, cross-sectional, and randomized controlled study that involves stratified randomization based on various factors such as age and type of cancer. The goal is to determine if this approach can lower the incidence of infections and complications associated with port and central venous catheters in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are children aged 1 to 17 who are receiving inpatient treatment for hematological or oncological cancers and have a port catheter inserted.
Not a fit: Patients with existing systemic infections will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of serious infections in pediatric cancer patients requiring catheterization.
How similar studies have performed: Other studies have shown promising results with similar care bundle approaches in reducing catheter-related infections, suggesting potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit * The child has a diagnosis of hematological or oncological cancer * The child's age range is between 1 and 17 * Having a port catheter inserted and no early complications have occurred * The child agrees to participate in the study voluntarily * The parent agrees to participate in the study voluntarily * Obtaining the consent form from the child and parent * He has been in the hospital for more than 48 hours Exclusion Criteria: * Have a systemic infection.
Where this trial is running
Izmir
- Gülçin Özalp Gerçeker — Izmir, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Gulcin Ozalp Gerceker, Assoc. Prof. — Dokuz Eylul University
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.